CNTB

Conviction 22HealthcareScan · Thu, Jun 25, 2026

CNTB$2.08-2.12%

ResistanceSupportVol 14Insider buy

Vol MA14 345.18K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Connect Biopharma Holdings LtdPHARMACEUTICAL PREPARATIONSwww.connectbiopharm.com ↗

Price2.08

Change-2.12%

Gap+2.36%

Rel volume0.93×

Avg volume318.43K

Avg $ vol675.87K

SMA 202.15

SMA 502.36

SMA 2002.32

Price vs 50-11.98%

Price vs 200-10.68%

MA stackmixed

50/200 cross—

Supertrenddown · 2.57

RSI (14)43

MACD hist0.01

MACD crossbull · 1d

Stoch %K / %D31 / 33

ADX (14)8

+DI / −DI15 / 13

RSI divergence—

MACD divergence—

ATR %+8.97%

ADR %8.48%

52w high3.69

52w low0.9523

From 52w high-43.77%

Above 52w low+117.89%

New 52w highNo

SqueezeOn · 2d

Bollinger width24.28%

%B0.35

Donchian pos25.83%

Donchian high2.52

Donchian low1.92

AVWAP (52w high)2.55

vs AVWAP high-18.59%

AVWAP (52w low)2.40

vs AVWAP low-13.68%

OBV trendFlat

Chaikin MF (20)-0.32

Today vs 20d0.93×

Avg vol (14d)345.18K

Avg vol (20d)318.43K

Avg $ vol (20d)675.87K

Market cap130.65M

RS 3m (vs SPY)-44.53%

RS 6m (vs SPY)-14.34%

RS line new highNo

Trend template3/8

Technical rank22.3

1 week-0.24%

1 month-13.54%

3 months-38.24%

6 months-18.31%

1 year+117.12%

YTD-17.66%

P/E-2.35

P/B3.07

P/S—

P/FCF-2.53

EPS-1.00

Div yield—

ROE-130.16%

ROA-92.37%

Debt/Eq—

Current3.23

EV/EBITDA-1.47

Gross margin—

Net margin—

Rev growth-99.75%

EPS growth-255.00%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value84.62M

Revenue169K

Net income-19.4M

Gross profit—

Free cash flow-51.64M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out62.96M

Employees64

ListedWed, Sep 3, 2025

Free float56.52M

Float %100.0%

Short interest1.17M

Days to cover5.9d

Short volume67.3%

Squeeze score47 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank22.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.71

Support2.04

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CNTB

All disclosures →

No recent disclosed trades by Congress in CNTB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNTB · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Huang James Director · Ordinary Shares · 2026-05-29	Buy	150K	$372K	2026-05-29	2026-06-02

SEC filings

EDGAR filings in CNTB

EDGAR →

No recent SEC filings on file for CNTB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.